PHOTOSTABILITY STUDY AND IDENTIFICATION OF PHOTODEGRADATION PRODUCTS OF ZIPRASIDONE BY UHPLC-DAD/ESI-Q-TOF

REFERENCES

• Rosa , A. R. ; Franco , C. ; Torrent , C. ; Comes , M. ; Cruz , N. ; Horga , G. ; Benabarre , A. ; Vieta , E. Ziprasidone in the Treatment of Affective Disorders: A Review . CNS Neurosci. Therap. 2008 , 14 ( 4 ), 278 – 286 .
   PubMed Web of Science ®Google Scholar
• DelBello , M. P. ; Versavel , M. ; Ice , K. ; Keller , D. ; Miceli , J. Tolerability of Oral Ziprasidone in Children and Adolescents with Bipolar Mania, Schizophrenia, or Schizoaffective Disorder . J. Child Adolesc. Psychopharm. 2008 , 18 ( 5 ), 491 – 499 .
   PubMed Web of Science ®Google Scholar
• ICH International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Photostability Testing of New Drug Substances and Products. Q1B. 1996, IFPMA, Geneva.
   Google Scholar
• ICH International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Stability Testing of New Drug Substances and Products. Q1A. 2003, IFPMA, Geneva.
   Google Scholar
• Aman , W. ; Thoma , K. The Influence of Formulation and Manufacturing Process on the Photostability of Tablets . Int. J. Pharm. 2002 , 243 ( 1–2 ), 33 – 41 .
   PubMed Web of Science ®Google Scholar
• Tønnesen , H. H. Formulation and Stability Testing of Photolabile Drugs . Int. J. Pharm. 2001 , 225 ( 1–2 ), 1 – 14 .
   PubMed Web of Science ®Google Scholar
• Clothier , R. H. Phototoxicity and Acute Toxicity Studies Conducted by the FRAME Alternatives Laboratory: A Brief Review . Altern. Lab. Anim. 2007 , 35 ( 5 ), 515 – 519 .
   PubMed Web of Science ®Google Scholar
• Zhang , G. ; Terry Jr. , A.V. ; Bartlett , M. G. Determination of the Lipophilic Antipsychotic Drug Ziprasidone in Rat Plasma and Brain Tissue Using Liquid Chromatography-Tandem Mass Spectrometry . Biomed. Chromatogr. 2008 , 22 ( 7 ), 770 – 778 .
   PubMed Web of Science ®Google Scholar
• Zhang , G. ; Terry Jr. , A.V. ; Bartlett , M. G. Liquid Chromatography/Tandem Mass Spectrometry Method for the Simultaneous Determination of Olanzapine, Risperidone, 9-Hydroxyrisperidone, Clozapine, Haloperidol and Ziprasidone in Rat Plasma . Rapid Comm. Mass Spectro. 2007 , 21 ( 6 ), 920 – 928 .
   PubMed Web of Science ®Google Scholar
• Aravagiri , M. ; Marder , S. R. ; Pollock , B. Determination of Ziprasidone in Human Plasma by Liquid Chromatography–Electrospray Tandem Mass Spectrometry and Its Application to Plasma Level Determination in Schizophrenia Patients . J. Chromatogr. B 2006 , 847 ( 2 ), 237 – 244 .
   PubMed Web of Science ®Google Scholar
• Kirchherr , H. ; Kuhn-Velter , W. N. Quantitative Determination of Forty-Eight Antidepressants and Antipsychotics in Human Serum by HPLC Tandem Mass Spectrometry . J. Chromatogr. B 2006 , 843 ( 1 ), 100 – 113 .
   PubMed Web of Science ®Google Scholar
• Al-Dirbashi , O. Y. ; Aboul-Enein , H. Y. ; Al-Odaib , A. ; Jacob , M. ; Rashed , M. S. Rapid Liquid Chromatography-Tandem Mass Spectrometry Method for Quantification of Ziprasidone in Human Plasma . Biomed. Chromatogr. 2006 , 20 ( 4 ), 365 – 368 .
   PubMed Web of Science ®Google Scholar
• Miao , Z. ; Kamel , A. ; Prakash , C. Characterization of a Novel Metabolite Intermediate of Ziprasidone in Hepatic Cytosolic Fractions of Rat, Dog, and Human by ESI-MS/MS, Hydrogen/Deuterium Exchange, and Chemical Derivatization . Drug Matabol. Disp. 2005 , 33 ( 7 ), 879 – 883 .
   PubMed Web of Science ®Google Scholar
• Sachse , J. ; Hartter , S. ; Hiemke , C. Automated Determination of Ziprasidone by HPLC with Column Switching and Spectrophotometric Detection. Ther. Drug Monit. 2005, 27 (2), 158–162.
   PubMed Web of Science ®Google Scholar
• Janiszewski , J. S. ; Fouda , H. G. ; Cole , R. O. Development and Validation of a High-Sensitivity Assay for an Antipsychotic Agent, CP-88,059, with Solid-Phase Extraction and Narrow-Bore High-Performance Liquid Chromatography . J. Chromatogr. B 1995 , 668 ( 1 ), 133 – 139 .
   PubMed Web of Science ®Google Scholar
• Suckow , R. F. ; Fein , M. ; Correll , C. U. ; Cooper , T. B. Determination of Plasma Ziprasidone Using Liquid Chromatography with Fluorescence Detection . J. Chromatogr. B 2004 , 799 ( 2 ), 201 – 208 .
   PubMed Web of Science ®Google Scholar
• Vijayalakshmi , R. ; Chandra , B. S. ; Sravya , K. ; Jahnavi , N. ; Dhanaraju , M. D. Spectrophotometric Determination of Ziprasidone Hydrochloride in Pharmaceutical Formulations . Orient. J. Chem. 2009 , 25 ( 4 ), 1097 – 1099 .
   Google Scholar
• Sreelakshmi , A. ; Devala Rao , G. ; Sudhakara Sai Babu , G. Visible Spectrophotometric Methods for Estimation of Ziprasidone in Pharmaceutical Dosage Forms . J. Chem. Pharm. Sci. 2010 , 3 ( 3 ), 154 – 156 .
   Google Scholar
• Anand Kumar , Y. ; Anitha , M. ; Hemanth , A. ; Srinivas , S. Development of Rapid UV Spectrophotometric Method for the Estimation of Ziprasidone Hydrochloride in Bulk and Formulations . Digest J. Nanomater. Biostruct. 2010 , 5 ( 1 ), 279 – 283 .
   Web of Science ®Google Scholar
• Farina , C. ; Kremser , L. ; Raggi , M. A. ; Kenndler , E. Determination of Ziprasidone in Pharmaceutical Formulations by Capillary Zone Electrophoresis . J. Pharm. Biomed. Anal. 2008 , 46 ( 3 ), 471 – 476 .
   PubMed Web of Science ®Google Scholar
• Kula , D. ; Gumustasb , M. ; Uslub , B. ; Ozkan , S. A. Electroanalytical Characteristics of Antipsychotic Drug Ziprasidone and Its Determination in Pharmaceuticals and Serum Samples on Solid Electrodes . Talanta 2010 , 82 ( 1 ), 286 – 295 .
   PubMed Web of Science ®Google Scholar
• Skibiński , R. ; Komsta , Ł. Validation of NP-HPTLC and RP-HPTLC Methods with Videodensitometric Detection for Analysis of Ziprasidone in Pharmaceutical Formulations . J. Planar Chromatogr. 2010 , 23 ( 1 ), 23 – 27 .
   Web of Science ®Google Scholar
• Li , N. ; Shen , S. ; Zhong , Y. ; Wang , Z. Y. ; Yu , Y. Q. Determination of Ziprasidone Hydrochloride by RP-HPLC with UV Detection . Fudan Univ. J. Med. Sci. 2004 , 31 ( 6 ), 656 – 657 .
   Google Scholar
• El-Sherif , Z. A. ; El-Zeany , B. ; El-Houssini , O. M. ; Rashed , M. S. ; Aboul-Enein , H. Y. Stability Indicating Reversed-Phase High-Performance Liquid Chromatographic and Thin Layer Densitometric Methods for the Determination of Ziprasidone in Bulk Powder and in Pharmaceutical Formulations . Biomed. Chromatogr. 2004 , 18 ( 3 ), 143 – 149 .
   PubMed Web of Science ®Google Scholar
• Singh , A. ; Rao , B.M. ; Deshpande , G.R. ; Sangaraju , S. ; Srinivasu , M.K. ; Lalitha Devi , M. ; Satyanarayana , P.V.V. ; Chandrasekhar , K.B. A Rapid Stability-Indicating LC Method for Ziprasidone Hydrochloride . Chromatogr. 2007 , 65 ( 3–4 ), 191 – 196 .
   Web of Science ®Google Scholar
• Walash , M. I. ; Belal , F. ; El-Enany , N. ; Eid , M. ; El-Shaheny , R. N. Stability-Indicating Spectrofluorimetric Method for the Assay of Ziprasidone in Capsules . J. Fluorescence . 2011 , 21 ( 4 ), 1659 – 1667 .
   PubMed Web of Science ®Google Scholar
• Mączka , P. ; Komsta , Ł. ; Skibiński , R. ; Gumieniczek , A. Theoretical studies on keto-enol tautomerism, gas phase acidity and spectra properties of phenylbutazone . Annales Universitatis Mariae Curie-Sklodowska, Sectio DDD: Pharmacia 2010 , 23 ( 3–4 ), 29 – 41 .
   Google Scholar